The current study presents the development and validation of a ultraviolet-visible (UV-Vis) spectroscopic method for the quantification of pregabalin in its bulk and marketed formulations. To perform this study, pregabalin was first derivatized by conducting a conventional diazotization procedure and then coupled with β-naphthol at 2–5°C. The formed adduct showed its highest absorption maximum at 355 nm within the range of 200–800 nm on the UV-Vis spectrum. Further, the developed method was validated as per International Council for Harmonization guidelines. The method was linear over the concentration range of 0.06 to 0.24 µg/mL (r2 = 0.9971), with limits of detection (0.001 µg/mL) and quantitation (0.003 µg/mL). Intra-day (mean recovery of 99.5%) and inter-day (mean recovery of 99.9%) precision were determined. The mean recovery in the accuracy study was between 99.7–100.4%. The method showed superiority over all the previously reported methods, featuring a rapid reaction, simplistic synthesis, shorter analysis time, and high sensitivity. Additionally, the method proved successful when applied to the quantification of marketed products.
Malviya et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: